BioCentury | Mar 20, 2014
Translation in Brief

Translational tidbits

At least $440 million in new support for public-private partnerships was allocated last month globally. Almost $230 million of that amount is earmarked for the NIH 's Accelerating Medicines Partnership 1 ( see "Selected public-private partnerships...
BioCentury | Mar 3, 2014
Company News

Pfizer, Massachusetts Institute of Technology (MIT) deal

MIT's Synthetic Biology Center and Pfizer partnered in a three-year research collaboration to translate discoveries in synthetic biology to advance drug discovery and development technologies, including cellular genome engineering. MIT and Pfizer declined to disclose...
BioCentury | Jun 28, 2010
Company News

CGI, Gilead deal

...Gilead will acquire CGI (formerly Cellular Genomics Inc. ) for up to $120 million in cash. An undisclosed...
BioCentury | Jun 25, 2010
Company News

Gilead to acquire CGI

...milestones. Gilead said the deal broadens its research into kinase biology and chemistry. CGI (formerly Cellular Genomics Inc....
BioCentury | Jan 4, 2010
Tools & Techniques

Celling cardiotox in a dish

Cellular Dynamics International Inc. has overcome a technical hurdle that has until now prevented the use of stem cell technologies to develop high throughput cell-based screens for preclinical toxicity studies. The company believes its iCell...
BioCentury | Oct 29, 2009
Tools & Techniques

More iPS cells in less time

A team at The Scripps Research Institute has found that a trio of small molecules can provide more than a 200-fold boost in the generation of induced pluripotent stem cells from human fibroblasts while cutting...
BioCentury | Oct 9, 2006
Company News

CGI, Genentech deal

...CGI $25 million up front, including license fees and an equity investment in CGI (formerly Cellular Genomics Inc....
BioCentury | Oct 4, 2006
Top Story

Genentech in-licenses CGI target

...CGI $25 million up front, including license fees and an equity investment in CGI (formerly Cellular Genomics...
BioCentury | May 2, 2005
Finance

MPM's portfolio

...10/20/04 $28.7 Michael Steinmetz Cellerant Cancer; Autoimmune; Transplant U.S. Series A 5/29/03 $10.0 Dennis Henner Cellular Genomics...
BioCentury | Mar 14, 2005
Company News

Cellular Genomics management update

Cellular Genomics Inc. , Branford, Conn. Business: Genomics, Functional genomics, Proteomics Hired: Peter Fuller as CBO, formerly SVP of business development at Molecular Staging Inc. WIR Staff...
Items per page:
1 - 10 of 50
BioCentury | Mar 20, 2014
Translation in Brief

Translational tidbits

At least $440 million in new support for public-private partnerships was allocated last month globally. Almost $230 million of that amount is earmarked for the NIH 's Accelerating Medicines Partnership 1 ( see "Selected public-private partnerships...
BioCentury | Mar 3, 2014
Company News

Pfizer, Massachusetts Institute of Technology (MIT) deal

MIT's Synthetic Biology Center and Pfizer partnered in a three-year research collaboration to translate discoveries in synthetic biology to advance drug discovery and development technologies, including cellular genome engineering. MIT and Pfizer declined to disclose...
BioCentury | Jun 28, 2010
Company News

CGI, Gilead deal

...Gilead will acquire CGI (formerly Cellular Genomics Inc. ) for up to $120 million in cash. An undisclosed...
BioCentury | Jun 25, 2010
Company News

Gilead to acquire CGI

...milestones. Gilead said the deal broadens its research into kinase biology and chemistry. CGI (formerly Cellular Genomics Inc....
BioCentury | Jan 4, 2010
Tools & Techniques

Celling cardiotox in a dish

Cellular Dynamics International Inc. has overcome a technical hurdle that has until now prevented the use of stem cell technologies to develop high throughput cell-based screens for preclinical toxicity studies. The company believes its iCell...
BioCentury | Oct 29, 2009
Tools & Techniques

More iPS cells in less time

A team at The Scripps Research Institute has found that a trio of small molecules can provide more than a 200-fold boost in the generation of induced pluripotent stem cells from human fibroblasts while cutting...
BioCentury | Oct 9, 2006
Company News

CGI, Genentech deal

...CGI $25 million up front, including license fees and an equity investment in CGI (formerly Cellular Genomics Inc....
BioCentury | Oct 4, 2006
Top Story

Genentech in-licenses CGI target

...CGI $25 million up front, including license fees and an equity investment in CGI (formerly Cellular Genomics...
BioCentury | May 2, 2005
Finance

MPM's portfolio

...10/20/04 $28.7 Michael Steinmetz Cellerant Cancer; Autoimmune; Transplant U.S. Series A 5/29/03 $10.0 Dennis Henner Cellular Genomics...
BioCentury | Mar 14, 2005
Company News

Cellular Genomics management update

Cellular Genomics Inc. , Branford, Conn. Business: Genomics, Functional genomics, Proteomics Hired: Peter Fuller as CBO, formerly SVP of business development at Molecular Staging Inc. WIR Staff...
Items per page:
1 - 10 of 50